Clinical Trials
1
Active:0
Completed:1
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Retrospective Study of Implants With Peri-implantitis Surgically Treated Using Enamel Matrix Derivative (EMD)
Completed
- Conditions
- Determination of Beneficial Effect of Using Enamel Matrix Derivative During Implant Treatment
- First Posted Date
- 2022-06-15
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- North Dallas Dental Health
- Target Recruit Count
- 34
- Registration Number
- NCT05419102
- Locations
- 🇺🇸
North Dallas Dental Health, Dallas, Texas, United States
News
No news found